Monday, October 25, 2010
Monday, October 18, 2010
Tuesday, October 12, 2010
Monday, October 11, 2010
Thursday, October 07, 2010
Wednesday, October 06, 2010
The purpose of this study was to investigate the influence of sustained 30 minutes of near work upon the length of the eye in patients that don't need vision correction and those that are near sighted.
A new product, MigraLens, designed to filter red and blue light and help migraine sufferers is now available in the UK in a range of branded plano eyewear including fit-overs for presciption glasses.
The flicker and glare absorbing filter has been trialled by its developer, Mediview, with members of the Macular Disease Society and now, Migraine Action too. Lee Tomkins, Director of Migraine Action, a UK charity that offers advice and support to migraine sufferers commented: “Our members have found that MigraLens is able to minimise the problems caused by flicker and glare and we are confident that it will become a useful new addition to existing migraine treatments available to light sensitive sufferers.”
Tuesday, October 05, 2010
PDT GIVES EARLIER RESOLUTION BUT EQUAL LONG-TERM OUTCOME COMPARED TO LASER THERAPY IN CENTRAL SEROUS RETINOPATHY
Compared with focal laser, half-dose PDT may facilitate earlier resolution of macular detachment and earlier recovery of central retinal function. However, at 3 months after treatment and thereafter, no difference in anatomical and functional recovery was noted between the two modalities of treatment.